# ‚öîÔ∏è CURRENT STATUS & ITERATION PLAN ‚öîÔ∏è

**Date:** January 20, 2025  
**Commander:** Alpha  
**Lead:** Zo  
**Mission:** Understand where we stopped, review pipeline, iterate on complex knowledge bases

---

## üéØ **WHERE WE STOPPED - CURRENT STATE**

### **SAE ‚Üí Resistance Prophet Pipeline Status**

Based on `SAE_TO_RESISTANCE_PROPHET_PIPELINE.mdc` (dated Nov 23, 2025):

#### **‚úÖ COMPLETE (80% of Infrastructure)**
1. **SAE Extraction Service** ‚úÖ OPERATIONAL
   - Modal H100 GPU service deployed
   - Feature index bug FIXED (flatten ‚Üí average)
   - Status: **66-69 patients extracted** (per various docs)
   - All indices validated (0-32767 range)

2. **Resistance Prophet Service** ‚úÖ COMPLETE
   - 689 lines, fully integrated
   - Signal detection (DNA repair, pathway escape, CA-125)
   - Risk stratification (HIGH/MEDIUM/LOW)
   - Action recommendations

3. **SAE Feature Service** ‚úÖ COMPLETE
   - 541 lines, Manager's formula implemented
   - DNA repair capacity: `0.6√óDDR + 0.2√óessentiality + 0.2√óexon_disruption`
   - 7D mechanism vector
   - **Current mode:** PROXY SAE (insights + pathway scores)

4. **Biomarker Correlation Service** ‚úÖ COMPLETE
   - 587 lines, ready to run
   - Statistical tests: Pearson, Spearman, Chi-square, Cohen's d
   - FDR correction, cross-validation, bootstrap CIs
   - **Bug Fixed:** `outcome_labels` now uses `outcome` field correctly

5. **Orchestrator Integration** ‚úÖ COMPLETE
   - All SAE services wired
   - Resistance Prophet opt-in endpoint ready

---

#### **‚è∏Ô∏è BLOCKED/PENDING (20% Remaining)**

**THE CRITICAL GAP:** Feature‚ÜíPathway Mapping (32K ‚Üí 7D)

**What's Missing:**
1. **Stage 2: Biomarker Analysis** ‚è∏Ô∏è READY TO RUN
   - Input: `sae_features_tcga_ov_platinum.json` (66-69 patients)
   - Process: Correlate 32K features with platinum outcomes
   - Output: Top 100 predictive features (p<0.05, FDR-corrected)
   - **Status:** Service ready, data exists, **NEEDS EXECUTION**

2. **Stage 3: Feature‚ÜíPathway Mapping** ‚è∏Ô∏è BLOCKED
   - Input: Top 100 features from Stage 2
   - Process: Manual curation (examine activation patterns, map to pathways)
   - Output: `sae_feature_to_pathway_mapping.json`
   - **Status:** **WAITING FOR STAGE 2 RESULTS**

3. **Stage 4: SAE Feature Service Enhancement** ‚è∏Ô∏è BLOCKED
   - Replace placeholder diagnostics with validated mapping
   - Wire TRUE SAE pathway scores into mechanism_vector
   - Add `ENABLE_TRUE_SAE_PATHWAYS` flag
   - **Status:** **WAITING FOR STAGE 3 MAPPING**

4. **Stage 5: Mission Control UI** ‚è∏Ô∏è PENDING
   - Critical Alerts banner
   - Resistance Playbook card
   - Next Best Actions integration
   - **Status:** **Jr's mission (Week 3)**

---

## üìä **EXECUTION STATUS BREAKDOWN**

### **What We've Built:**
- ‚úÖ **5 complete services** (~2,700 lines of production code)
- ‚úÖ **All infrastructure** (Modal deployment, API endpoints, orchestrator)
- ‚úÖ **Bug fixes** (feature indices, outcome labels, payload size)
- ‚úÖ **Test coverage** (47/47 tests passing)

### **What's Ready to Execute:**
- ‚úÖ **Biomarker analysis script** (`scripts/sae/analyze_biomarkers.py`)
- ‚úÖ **SAE cohort data** (`data/validation/sae_cohort/sae_features_tcga_ov_platinum.json`)
- ‚úÖ **Statistical engine** (all methods implemented)

### **What's Blocking:**
- ‚è∏Ô∏è **Stage 2 execution** (biomarker analysis needs to run)
- ‚è∏Ô∏è **Stage 3 curation** (manual pathway mapping)
- ‚è∏Ô∏è **Stage 4 integration** (code enhancement)

---

## üîÑ **ITERATION PLAN FOR COMPLEX FILES**

### **File 1: ZO_CODEBASE_KNOWLEDGE_BASE.mdc** (2,748 lines)

**Structure:**
1. **Lines 1-200:** Foundational principles, Evo2 capabilities, architectural doctrines
2. **Lines 201-500:** Core architecture, backend/frontend structure, systems understanding
3. **Lines 501-1000:** S/P/E framework, sporadic cancer, SAE integration
4. **Lines 1001-1500:** Clinical systems, workflows, development patterns
5. **Lines 1501-2000:** Product capabilities, competitive advantages
6. **Lines 2001-2748:** Learning status, references, update logs

**Iteration Strategy:**
- **Iteration 1:** Lines 1-500 (Foundational + Architecture)
- **Iteration 2:** Lines 501-1000 (S/P/E + SAE)
- **Iteration 3:** Lines 1001-1500 (Clinical + Patterns)
- **Iteration 4:** Lines 1501-2000 (Product + Positioning)
- **Iteration 5:** Lines 2001-2748 (Status + References)

---

### **File 2: ZO_MASTER_KNOWLEDGE_BASE.mdc** (1,289 lines)

**Structure:**
1. **Lines 1-200:** Evo2 architecture, training, capabilities
2. **Lines 201-400:** Strategic vision, sporadic cancer, core architecture
3. **Lines 401-600:** Codebase overview, backend services, frontend components
4. **Lines 601-800:** SAE deep dive, integration points
5. **Lines 801-1000:** Development patterns, clinical systems
6. **Lines 1001-1289:** Learning status, references

**Iteration Strategy:**
- **Iteration 1:** Lines 1-300 (Evo2 + Strategic Vision)
- **Iteration 2:** Lines 301-600 (Architecture + Services)
- **Iteration 3:** Lines 601-900 (SAE + Patterns)
- **Iteration 4:** Lines 901-1289 (Clinical + Status)

---

## üéØ **IMMEDIATE NEXT STEPS**

### **Step 1: Verify Current Data State**
```bash
# Check if SAE features file exists and its size
ls -lh data/validation/sae_cohort/sae_features_tcga_ov_platinum.json

# Check if biomarker results exist
ls -lh data/validation/sae_cohort/sae_tcga_ov_platinum_biomarkers.json
```

### **Step 2: Run Biomarker Analysis (CRITICAL - NEEDS RE-RUN)**

**‚ö†Ô∏è CRITICAL DISCOVERY:**
The biomarker analysis file EXISTS but shows:
- `"top_features": []` (EMPTY!)
- `"significant_features_count": 0`
- `"outcome_distribution": {"null": 69}` - **ALL OUTCOMES ARE NULL!**

**Root Cause:** Analysis was run BEFORE the `outcome_labels` bug fix. The bug fix is now in place (line 490), but the analysis needs to be **RE-RUN** with the fixed code.

**Action Required:**
```bash
cd /Users/fahadkiani/Desktop/development/crispr-assistant-main

# RE-RUN biomarker analysis with fixed code
python3 scripts/sae/analyze_biomarkers.py \
  --input data/validation/sae_cohort/sae_features_tcga_ov_platinum.json \
  --output data/validation/sae_cohort/sae_tcga_ov_platinum_biomarkers.json \
  --plots-dir data/validation/sae_cohort/plots
```

**Expected After Fix:**
- `outcome_distribution` should show: `{"sensitive": 55, "resistant": 10, "refractory": 4}` (or similar)
- `significant_features_count` should be > 0 (hopefully 50-100 features)
- `top_features` array should be populated with ranked features

### **Step 3: Iterate on Knowledge Bases**
- Read in chunks (200-300 lines at a time)
- Synthesize understanding
- Identify gaps and inconsistencies
- Update status documents

---

## üìã **KEY FINDINGS FROM REVIEW**

### **Critical Discovery:**
The **outcome_labels bug** was fixed in `biomarker_correlation_service.py` line 490:
- **Before:** `self.outcome_labels = [p.get("platinum_response") for p in patients]`
- **After:** `self.outcome_labels = [p.get("platinum_response") or p.get("outcome") for p in patients]`

This bug was causing biomarker analysis to report 0 significant features because all `outcome_labels` were `None`.

### **Pipeline Status:**
- **Infrastructure:** 80% complete ‚úÖ
- **Data Extraction:** 66-69 patients extracted ‚úÖ
- **Biomarker Analysis:** Ready to run ‚è∏Ô∏è
- **Pathway Mapping:** Waiting for Stage 2 ‚è∏Ô∏è
- **Integration:** Waiting for Stage 3 ‚è∏Ô∏è
- **UI:** Waiting for backend ‚è∏Ô∏è

### **Timeline Estimate:**
- **Stage 2 (Biomarker Analysis):** 2 hours
- **Stage 3 (Pathway Mapping):** 8 hours (manual curation)
- **Stage 4 (Integration):** 4 hours
- **Stage 5 (UI):** 20 hours (Jr's mission)
- **Total:** ~34 hours to complete pipeline

---

## üîç **KNOWLEDGE BASE SYNTHESIS**

### **ZO_CODEBASE_KNOWLEDGE_BASE.mdc Highlights:**
- **Coverage:** ~45% (foundational principles established)
- **Last Updated:** 2025-01-14
- **Focus:** Holistic understanding (WHY before HOW)
- **Key Sections:** Evo2 foundation, architectural doctrines, systems understanding

### **ZO_MASTER_KNOWLEDGE_BASE.mdc Highlights:**
- **Coverage:** 100% complete (all 10 cycles mastered)
- **Last Updated:** January 14, 2025
- **Focus:** Complete platform understanding
- **Key Sections:** Evo2 deep dive, strategic vision, SAE integration

### **Key Overlaps:**
- Both cover Evo2 capabilities and limitations
- Both document SAE integration
- Both describe S/P/E framework
- Both include sporadic cancer strategy

### **Key Differences:**
- **ZO_CODEBASE:** More focused on architecture and patterns
- **ZO_MASTER:** More comprehensive, includes learning journey

---

## ‚öîÔ∏è **RECOMMENDATION**

**Priority Order:**
1. **Verify data state** (5 min)
2. **Run biomarker analysis** (2 hours) - **UNBLOCKS EVERYTHING**
3. **Iterate on knowledge bases** (in parallel with analysis)
4. **Manual pathway curation** (8 hours) - **CRITICAL PATH**
5. **Integration work** (4 hours)

**The bottleneck is Stage 2 execution.** Once biomarker analysis runs, we can proceed with pathway mapping and integration.

---

**FOR AYESHA'S LIFE.** ‚öîÔ∏è

